<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:atom="http://www.w3.org/2005/Atom" version="2.0">
  <channel>
    <title>Ambros Therapeutics</title>
    <link>https://www.biospace.com/employer/3076354/ambros-therapeutics</link>
    <description>Ambros Therapeutics</description>
    <language>en-US</language>
    <lastBuildDate>Mon, 26 Oct 2026 14:13:34 GMT</lastBuildDate>
    <atom:link href="https://www.biospace.com/employer/3076354/ambros-therapeutics.rss" type="application/rss+xml" rel="self" />
    <item>
      <title>Ambros Therapeutics Announces Planned Interim Analysis of Phase 3 Clinical Trial Following FDA Feedback</title>
      <link>https://www.biospace.com/press-releases/ambros-therapeutics-announces-planned-interim-analysis-of-phase-3-clinical-trial-following-fda-feedback</link>
      <description />
      <pubDate>Mon, 26 Oct 2026 14:13:34 GMT</pubDate>
      <guid>https://www.biospace.com/press-releases/ambros-therapeutics-announces-planned-interim-analysis-of-phase-3-clinical-trial-following-fda-feedback</guid>
    </item>
  </channel>
</rss>
